[Form 4] CARTERS INC Insider Trading Activity
Hali Borenstein, a director of Carter's, Inc. (CRI), received 16.8031 shares of the issuer's common stock on 09/12/2025 at no cash cost under the companys director deferred compensation program. Following the transaction, the reporting persons total beneficial ownership is reported as 16,991.8143 shares. The Form 4 was filed by one reporting person and signed by an attorney-in-fact on 09/12/2025. The filing explains these shares were credited as a dividend payment and will be settled pursuant to the deferred compensation plan.
Hali Borenstein, una direttrice di Carter's, Inc. (CRI), ha ricevuto 16.8031 azioni ordinarie dell’emittente il 12/09/2025 senza alcun costo in contanti nell’ambito del programma di compensazione differita per i direttori dell’azienda. Dopo la transazione, la proprietàBeneficiaria Totale riportata è di 16.991.8143 azioni. Il Modulo 4 è stato presentato da una persona dichiarante e firmato da un procuratore il 12/09/2025. Il modulo spiega che queste azioni sono state accreditate come pagamento di dividendi e saranno regolate ai sensi del piano di compensazione differita.
Hali Borenstein, directora de Carter's, Inc. (CRI), recibió 16.8031 acciones ordinarias del emisor el 12/09/2025 sin costo en efectivo, bajo el programa de compensación diferida para directores de la empresa. Tras la transacción, la participación total de propiedad beneficiosa reportada es de 16.991.8143 acciones. El Formulario 4 fue presentado por una persona informante y firmado por un apoderado el 12/09/2025. El documento explica que estas acciones fueron creditadas como pago de dividendos y serán liquidadas conforme al plan de compensación diferida.
헤일 보렌스타인(Hali Borenstein)은 Carter's, Inc. (CRI)의 이사로서 2025년 9월 12일 현금 없이 발행사 보통주 16.8031주를 수령했습니다. 이는 회사의 이사용 지연 보상 제도 하에서 이루어졌습니다. 거래 후 보고자의 총 유익 보유 주식수는 16.991.8143주로 보고됩니다. Form 4는 한 명의 보고자가 제출했고 2025년 9월 12일 대리인에 의해 서명되었습니다. 공시에는 이 주식이 배당금으로 적립되었고 지연 보상 계획에 따라 결제될 것이라고 설명되어 있습니다.
Hali Borenstein, administratrice chez Carter's, Inc. (CRI), a reçu 16,8031 actions ordinaires de l’émetteur le 12/09/2025 sans coût cash, dans le cadre du programme de rémunération différée des administrateurs de l’entreprise. Suite à la transaction, la détention bénéficiaire totale reportée est de 16.991.8143 actions. Le Formulaire 4 a été déposé par une personne déclarant et signé par un mandataire le 12/09/2025. Le dépôt explique que ces actions ont été créditées en tant que paiement de dividendes et seront réglées conformément au plan de rémunération différée.
Hali Borenstein, eine Direktorin bei Carter's, Inc. (CRI), hat am 12.09.2025 16,8031 Stammaktien des Emittenten ohne Bareinzahlung im Rahmen des Vorstands- deferred compensation-Programms erhalten. Nach der Transaktion wird das insgesamt gemeldete beherrschende Eigentum mit 16.991.8143 Aktien angegeben. Das Formular 4 wurde von einer meldenden Person eingereicht und am 12.09.2025 von einem Prokuristen unterzeichnet. Die Einreichung erklärt, dass diese Aktien als Dividendenzahlung gutgeschrieben wurden und gemäß dem Deferred-Compensation-Plan abgewickelt werden.
هيلى بورنسترن، مديرة في Carter's, Inc. (CRI)، تلقّت 16.8031 سهماً عاديّاً للمُصدر في 12/09/2025 بدون أي تكلفة نقدية، ضمن برنامج تعويضات مديرين مؤجَّلة للشركة. عقب الصفقة، تُذكر الملكية المفيدة الإجمالية للمُعلَن عنها كـ16.991.8143 سهماً. تم تقديم النموذج 4 من قبل شخص مُصرّح به وتوقيعه من قبل وكيل مفوَّض في 12/09/2025. يشرح المستند أن هذه الأسهم أُدرِجَت كدفعة أرباح وسيتم تسويتها وفقاً لخطة التعويض المؤجَّل.
Hali Borenstein,Carter's, Inc. (CRI) 的董事,于2025年9月12日,在公司的董事延期补偿计划下,获得了16.8031股发行人普通股,未产生现金成本。交易后,报告人总受益所有权被记为16,991.8143股。Form 4 由一名申报人提交,并由代理人于2025年9月12日签署。申报文件说明这些股票被记入股息支付,并将按照延期补偿计划进行结算。
- Director received equity compensation via the company's deferred compensation program, aligning director interests with shareholders
- Transaction is administrative and non-cash, indicating no immediate insider selling pressure
- None.
Insights
TL;DR: Director received a small number of shares via deferred compensation dividend; routine, non-cash transaction with limited investor impact.
The Form 4 documents a typical director compensation settlement: 16.8031 common shares were credited at $0 under the companys director deferred compensation program and added to the reporting persons beneficial holdings, bringing the total to 16,991.8143 shares. This is an administrative issuance tied to compensation and dividends rather than a market purchase or sale. There is no indication of exercise of options, cash consideration, or changes to board status. Materiality to shareholders is minimal given the small number of shares and the non-cash nature of the transaction.
TL;DR: Reported issuance is a dividend-related credit to a director's deferred compensation account; not a market-moving event.
The transaction date is 09/12/2025 and the filing shows an acquisition code (A) of 16.8031 shares at a reported price of $0, consistent with shares issued as compensation/dividend credits. The filing was singular (one reporting person) and executed by an attorney-in-fact. No derivative transactions, dispositions, or other securities activity are reported. For investors focused on insider trading activity, this entry signals routine compensation mechanics rather than insider buying or selling based on corporate developments.
Hali Borenstein, una direttrice di Carter's, Inc. (CRI), ha ricevuto 16.8031 azioni ordinarie dell’emittente il 12/09/2025 senza alcun costo in contanti nell’ambito del programma di compensazione differita per i direttori dell’azienda. Dopo la transazione, la proprietàBeneficiaria Totale riportata è di 16.991.8143 azioni. Il Modulo 4 è stato presentato da una persona dichiarante e firmato da un procuratore il 12/09/2025. Il modulo spiega che queste azioni sono state accreditate come pagamento di dividendi e saranno regolate ai sensi del piano di compensazione differita.
Hali Borenstein, directora de Carter's, Inc. (CRI), recibió 16.8031 acciones ordinarias del emisor el 12/09/2025 sin costo en efectivo, bajo el programa de compensación diferida para directores de la empresa. Tras la transacción, la participación total de propiedad beneficiosa reportada es de 16.991.8143 acciones. El Formulario 4 fue presentado por una persona informante y firmado por un apoderado el 12/09/2025. El documento explica que estas acciones fueron creditadas como pago de dividendos y serán liquidadas conforme al plan de compensación diferida.
헤일 보렌스타인(Hali Borenstein)은 Carter's, Inc. (CRI)의 이사로서 2025년 9월 12일 현금 없이 발행사 보통주 16.8031주를 수령했습니다. 이는 회사의 이사용 지연 보상 제도 하에서 이루어졌습니다. 거래 후 보고자의 총 유익 보유 주식수는 16.991.8143주로 보고됩니다. Form 4는 한 명의 보고자가 제출했고 2025년 9월 12일 대리인에 의해 서명되었습니다. 공시에는 이 주식이 배당금으로 적립되었고 지연 보상 계획에 따라 결제될 것이라고 설명되어 있습니다.
Hali Borenstein, administratrice chez Carter's, Inc. (CRI), a reçu 16,8031 actions ordinaires de l’émetteur le 12/09/2025 sans coût cash, dans le cadre du programme de rémunération différée des administrateurs de l’entreprise. Suite à la transaction, la détention bénéficiaire totale reportée est de 16.991.8143 actions. Le Formulaire 4 a été déposé par une personne déclarant et signé par un mandataire le 12/09/2025. Le dépôt explique que ces actions ont été créditées en tant que paiement de dividendes et seront réglées conformément au plan de rémunération différée.
Hali Borenstein, eine Direktorin bei Carter's, Inc. (CRI), hat am 12.09.2025 16,8031 Stammaktien des Emittenten ohne Bareinzahlung im Rahmen des Vorstands- deferred compensation-Programms erhalten. Nach der Transaktion wird das insgesamt gemeldete beherrschende Eigentum mit 16.991.8143 Aktien angegeben. Das Formular 4 wurde von einer meldenden Person eingereicht und am 12.09.2025 von einem Prokuristen unterzeichnet. Die Einreichung erklärt, dass diese Aktien als Dividendenzahlung gutgeschrieben wurden und gemäß dem Deferred-Compensation-Plan abgewickelt werden.